Popliteal Sciatic Nerve Block and Adductor Canal Block
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05960422 |
Recruitment Status :
Completed
First Posted : July 25, 2023
Last Update Posted : August 1, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The goal of this observational study is to determine the effect of adding adductor canal block to popliteal sciatic nerve block on patient-surgeon satisfaction, intraoperative sedation need, tourniquet pain, return time of motor block, and postoperative pain in patients undergoing hallux valgus correction surgery. The main question it aims to answer are:
- Does peroperative pain decrease?
- Do patient-surgeon satisfaction increase? The patients were divided into two groups, the Popliteal Sciatic Block (PSB) group, and the Popliteal Sciatic Block + Adductor Canal Block (PSB + ACB) group.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Popliteal Sciatic Nerve Block Adductor Canal Block | Procedure: Popliteal Sciatic Nerve Block Procedure: Adductor canal block | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 52 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Effects of Adding Adductor Canal Block to Popliteal Sciatic Nerve Block in Hallux Valgus Correction Operations |
Actual Study Start Date : | September 1, 2021 |
Actual Primary Completion Date : | January 10, 2022 |
Actual Study Completion Date : | February 10, 2022 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Popliteal Sciatic Nerve Block
Patients are in the group undergoing popliteal sciatic block
|
Procedure: Popliteal Sciatic Nerve Block
Patients undergoing popliteal sciatic block, the side where the procedure would be performed in the prone position was sterilized after appropriate antisepsis. After visualizing the popliteal artery in the popliteal fossa with the probe it was advanced proximally in a horizontal and minimally lateral position to determine the point of separation of the tibial and peroneal nerves from the sciatic nerve. Subcutaneous local anesthesia was applied at this point after the skin, and the stimulator needle was advanced towards the sciatic nerve in an in-plane approach, passing through the skin and subcutaneous tissue, and then the nerve stimulator was opened up to 1 mA. After observing motor movement in the foot, the stimulator was reduced to 0.3-0.5 mA, and after observing motor movements for duration of 0.1 ms, 10 ml of 0.5% bupivacaine + 10 ml of 2% prilocaine were administered to the target tissue |
Active Comparator: Adductor Canal Block
Patients are in the group undergoing popliteal sciatic block + adductor canal block
|
Procedure: Adductor canal block
Patients in the group undergoing popliteal sciatic block + adductor canal block, with the extremity to be blocked slightly externally rotated, the anterior part of the thigh was prepared with the necessary antiseptic procedures while the patient was in the supine position. Using an ultrasound probe, the femoral artery was visualized by advancing the ultrasound probe distally, and the saphenous nerve was identified just lateral to the femoral artery, beneath the sartorius muscle. At the junction of the sartorius muscle and vastus medialis, 10 ml of 0.5% bupivacaine + 10 ml of 2% prilocaine were applied to the periphery of the saphenous nerve. Subsequently, the patient was turned prone, and a popliteal sciatic block was performed. |
- Postoperative Pain [ Time Frame: Postoperative 24 hours ]The Numeric Pain Rating Scale (NPRS). Between 1-10. The low values mean low pain and a better outcome.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients aged between 18 and 80
- American Society of Anesthesiologists ASA I-III
Exclusion Criteria:
- Patients with coagulopathy
- Patient with wounds or infections in the region
- Patient with allergies to local anesthetic drugs
- Patient with significantly impaired peripheral neuropathy and neurogenic disorders affecting the lower extremity
- Patient with peripheral arterial disease
- Patient with mental retardation
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05960422
Turkey | |
Istanbul Medeniyet University Faculty of Medicine Department of Anesthesiology and Reanimation | |
Istanbul, Kadikoy, Turkey, 34720 |
Principal Investigator: | Ezgi Polat | İstanbul Medeniyet University |
Responsible Party: | Ezgi POLAT, Principal Investigator, Istanbul Medeniyet University |
ClinicalTrials.gov Identifier: | NCT05960422 |
Other Study ID Numbers: |
EzgiPOLAT |
First Posted: | July 25, 2023 Key Record Dates |
Last Update Posted: | August 1, 2023 |
Last Verified: | July 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Popliteal sciatic block, adductor canal block |